[Primary pigmented nodular adrenocortical disease (PPNAD)].
Omura
Masao
M
Division of Endocrinology and Metabolism, Department of Medicine, Social Insurance Central General Hospital.
D000302:Adrenal Cortex / Q000378:metabolism / Q000473:pathology; D000303:Adrenal Cortex Diseases / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D003480:Cushing Syndrome / Q000209:etiology*; D054756:Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; D017868:Cyclic AMP-Dependent Protein Kinases / Q000235:genetics; D003937:Diagnosis, Differential; D006801:Humans; D006854:Hydrocortisone / Q000096:biosynthesis; D017495:Hyperpigmentation / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006965:Hyperplasia; D009154:Mutation; D011379:Prognosis
D054756:Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; C517834:PRKAR1A protein, human; D017868:Cyclic AMP-Dependent Protein Kinases; D006854:Hydrocortisone